EDSA
Edesa Biotech, Inc. · Healthcare · Market cap $39.7M
Insider Buying
$233K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 1, 2026
Brooks Michael J
Edesa Biotech, Inc. (EDSA) has 29 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 1, 2026.
Inside the rolling window, 2 insiders at Edesa Biotech, Inc. reported 8 open-market purchases totaling $233K and no open-market sales. The most active filer is Chief Executive Officer Nijhawan Pardeep with 7 filings. The most recent open-market filing is a purchase of 2,000 shares by President Brooks Michael J, dated Feb 26, 2026, worth $3K.
- Industry:Biotechnology
- CEO:Pardeep Nijhawan
- Employees:17
- HQ:Markham, ON, CA
- IPO:2010-06-21
| Source | |||||||
|---|---|---|---|---|---|---|---|
Brooks Michael JFirst filing | President | Purchase | 2,000 | $3K | Mar 11 | -37.8% | SEC ↗ |
| Chief Executive Officer | Purchase | 1,000 | $7K | Mar 10 | -40.3% | SEC ↗ | |
| Chief Executive Officer | Purchase | 10,000 | $39K | Mar 6 | -36.8% | SEC ↗ | |
| Chief Executive Officer | Purchase | 10,000 | $43K | Mar 5 | +14.1% | SEC ↗ | |
| Chief Executive Officer | Purchase | 10,000 | $36K | Mar 4 | -3.5% | SEC ↗ | |
| Chief Executive Officer | Purchase | 3,000 | $6K | Mar 3 | -5.3% | SEC ↗ | |
Nijhawan PardeepFirst filing | Chief Executive Officer | Purchase | 20,571 | $32K | Mar 2 | +80.7% | SEC ↗ |
Nijhawan PardeepFirst filing | Chief Executive Officer | Purchase | 30,000 | $67K | Mar 2 | +80.7% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does EDSA have?
Edesa Biotech, Inc. (EDSA) has 29 SEC Form 4 filings (32 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 1, 2026.
When was the most recent SEC Form 4 filing for EDSA?
The most recent Form 4 filing for EDSA on Tracefour is dated Sep 1, 2026.
Who is the most active insider at EDSA?
The most active SEC Form 4 filer at EDSA in the rolling window is Chief Executive Officer Nijhawan Pardeep, with 7 filings.
What is the net insider flow at EDSA over the last 6 months?
Over the trailing 180 days, insiders at EDSA have net bought $91K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at EDSA in the current window?
Inside the rolling window, insiders at EDSA bought $233K and sold $0 based on SEC Form 4 filings.
Can I get alerts for EDSA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Edesa Biotech, Inc. (EDSA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Edesa Biotech, Inc. is in the Healthcare sector.